Transcept Pharmaceuticals Inc (TSPT.OQ)

TSPT.OQ on NASDAQ Stock Exchange Global Market

2.12USD
17 Sep 2014
Price Change (% chg)

$0.04 (+1.92%)
Prev Close
$2.08
Open
$2.09
Day's High
$2.17
Day's Low
$2.09
Volume
2,861
Avg. Vol
33,264
52-wk High
$3.81
52-wk Low
$1.69

TSPT.OQ

Chart for TSPT.OQ

About

Transcept Pharmaceuticals, Inc. (Transcept) is a specialty pharmaceutical company focused on the development and commercialization of products that address therapeutic needs in the field of neuroscience. In November 2011, the United States Food and Drug Administration (FDA) approved its new drug application (NDA) for Intermezzo... (more)
No analyst recommendations are available for TSPT.OQ.

Overall

Beta: 0.79
Market Cap (Mil.): $40.81
Shares Outstanding (Mil.): 19.16
Dividend: 1.33
Yield (%): --

Financials

  TSPT.OQ Industry Sector
P/E (TTM): -- 146.41 33.29
EPS (TTM): -0.87 -- --
ROI: -26.88 -3.28 17.33
ROE: -26.88 -7.94 18.19
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks